Oculotect (Povidone K25)

Povidone K25 is a high‑molecular‑weight polymer that dissolves in water to form a viscous, film‑forming solution. When applied to the eye, it creates a protective layer that retains moisture, reduces friction, and stabilizes the tear film, thereby improving comfort and protecting the cornea.

The dosing regimen for Oculotect is determined by the prescribing clinician based on the specific indication and patient needs. Typically, one drop is instilled in the affected eye(s) as directed, and the frequency is adjusted according to therapeutic response.

Safety data for povidone K25 in pregnancy and lactation are limited. Because it is an inert excipient with minimal systemic absorption, it is generally considered low risk, but clinicians should evaluate the benefit‑risk profile for each patient and use it only if clearly needed.

To place an order, submit an enquiry on the Oculotect product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any required import documentation.

Compared with simple saline drops, Oculotect’s povidone K25 provides a higher viscosity and longer‑lasting film, offering extended moisture retention. Unlike some preservative‑containing drops, it is formulated as an inert polymer solution, reducing the risk of preservative‑related irritation while still delivering effective lubrication.

Oculotect should be stored at room temperature, preferably below 25 °C, in its original container. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and discard any product that appears discoloured or has passed its expiration date.

Oculotect is applied topically to the eye as a sterile drop. The patient should wash their hands, tilt the head back, gently pull down the lower eyelid, and place a single drop into the conjunctival sac. The eye should be closed briefly to allow the solution to spread evenly.

Although rare, serious adverse reactions can include allergic eye inflammation, corneal edema, or severe ocular pain. If any signs of hypersensitivity, persistent redness, vision changes, or intense discomfort occur, the product should be discontinued and medical attention sought promptly.

Oculotect should not be used by individuals with a known hypersensitivity to povidone or any of the formulation components. It is also contraindicated in eyes with active infection unless specifically directed by a healthcare professional, and it should be avoided in patients where contact lens wear is incompatible with the drop.